NCT06229665View on ClinicalTrials.gov

Study of Photobiomodulation to Treat Dry Age-Related Macular Degeneration (LIGHTSITEIIIB)

PHASE2/PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

October 25, 2023

Primary Completion Date

May 1, 2025

Study Completion Date

June 1, 2025

Conditions
Dry Age-related Macular Degeneration
Interventions
DEVICE

Valeda Light Delivery System

The Valeda Light Delivery System will deliver two alternating and sequential treatments of 590 nm and 850 nm for 35 seconds, or a total of 70 seconds; and 660 nm for 90 seconds, or a total of 180 seconds.

Trial Locations (7)

21749

Cumberland Valley Retina Consultants, Hagerstown

32701

Florida Eye Clinic, Altamonte Springs

78503

Gulf Coast Eye Institute, McAllen

90211

Retina Vitreous Associates Medical Group, Beverly Hills

94303

Stanford University, Palo Alto

98383

Retina Center Northwest, Silverdale

10003-4284

New York Ear and Eye Infirmary, New York

Sponsors

Lead Sponsor

LumiThera, Inc.
All Listed Sponsors
collaborator

National Eye Institute (NEI)

NIH

lead

LumiThera, Inc.

INDUSTRY